Unknown

Dataset Information

0

3CLpro inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials.

ABSTRACT:

SUBMITTER: Sisay M 

PROVIDER: S-EPMC7128271 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

3CL<sup>pro</sup> inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials.

Sisay Mekonnen M  

Pharmacological research 20200402

Similar Datasets

Unknown Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?
| S-EPMC7264155 | biostudies-literature
Unknown A Patent Review on SARS Coronavirus Main Protease (3CL<sup>pro</sup> ) Inhibitors.
| S-EPMC8653044 | biostudies-literature
Unknown Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CL<sup>pro</sup>.
| S-EPMC9499987 | biostudies-literature
Unknown Synthesis and Biological Evaluation of Quinolinone Compounds as SARS CoV 3CL<sup>pro</sup> Inhibitors.
| S-EPMC7159103 | biostudies-literature
Unknown The development of Coronavirus 3C-Like protease (3CL<sup>pro</sup>) inhibitors from 2010 to 2020.
| S-EPMC7409838 | biostudies-literature
Unknown An overview of potential inhibitors targeting non-structural proteins 3 (PL<sup>pro</sup> and Mac1) and 5 (3CL<sup>pro</sup>/M<sup>pro</sup>) of SARS-CoV-2.
| S-EPMC8382591 | biostudies-literature
Unknown A Bioluminescent 3CL<sup>Pro</sup> Activity Assay to Monitor SARS-CoV-2 Replication and Identify Inhibitors.
| S-EPMC8473059 | biostudies-literature
Unknown QSAR and molecular docking studies of isatin and indole derivatives as SARS 3CL<sup>pro</sup> inhibitors.
| S-EPMC10079496 | biostudies-literature
Unknown Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CL<sup>pro</sup> covalent inhibitors.
| S-EPMC8665847 | biostudies-literature
Unknown Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CL<sup>pro</sup>).
| S-EPMC8353992 | biostudies-literature